Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H31N5O3 |
| Molecular Weight | 401.5025 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(C=CC=C1)N2CCN(CCCNC3=C(C)C(=O)N(C)C(=O)N3C)CC2
InChI
InChIKey=HIHZDNKKIUQQSC-UHFFFAOYSA-N
InChI=1S/C21H31N5O3/c1-16-19(23(2)21(28)24(3)20(16)27)22-10-7-11-25-12-14-26(15-13-25)17-8-5-6-9-18(17)29-4/h5-6,8-9,22H,7,10-15H2,1-4H3
| Molecular Formula | C21H31N5O3 |
| Molecular Weight | 401.5025 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9490024 |
9.2 null [pKi] | ||
Target ID: CHEMBL232 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9249248 |
7.7 null [pKi] | ||
Target ID: CHEMBL223 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9249248 |
8.0 null [pKi] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions. | 2011-07 |
|
| Adventitia removal does not modify the alphaID-adrenoceptors response in aorta during hypertension and ageing. | 2009-07 |
|
| Smooth muscle alpha1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca2+ in hamster cremaster arterioles. | 2008-10 |
|
| Functional alpha(1)-adrenoceptor subtypes in human submandibular glands. | 2006-03 |
|
| Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor. | 2005-11 |
|
| Differential distribution of functional alph}1-adrenergic receptor subtypes along the rat tail artery. | 2005-08 |
|
| Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation. | 2004-10 |
|
| Chromatography studies on bio-affinity of nine ligands of alpha1-adrenoceptor to alpha1D subtypes overexpressed in cell membrane. | 2004-08 |
|
| Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists. | 2001-07-06 |
|
| Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes. | 2001-06 |
|
| Use of antisense oligonucleotides to verify the role of the alpha(1A)-adrenergic receptor in the contractility of the rat uterus post partum. | 2001-05 |
|
| Characterization of alpha1-adrenoceptor subtypes mediating noradrenaline-induced contraction of rat epididymal vas deferens in calcium-free medium. | 1999 |
|
| Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. | 1998-01-30 |
|
| Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. | 1997-09-15 |
|
| Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. | 1997-07 |
|
| Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. | 1996-07 |
|
| Hypotensive and hypertensive effects of catecholamines intrathecally injected in anesthetized rats. | 1996-06-10 |
|
| KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. | 1995-08 |
|
| Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. | 1994-07 |
|
| The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. | 1994-04 |
|
| Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. | 1993 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:00:19 GMT 2025
by
admin
on
Mon Mar 31 19:00:19 GMT 2025
|
| Record UNII |
1HLS600135
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
34661-85-3
Created by
admin on Mon Mar 31 19:00:19 GMT 2025 , Edited by admin on Mon Mar 31 19:00:19 GMT 2025
|
PRIMARY | |||
|
5640
Created by
admin on Mon Mar 31 19:00:19 GMT 2025 , Edited by admin on Mon Mar 31 19:00:19 GMT 2025
|
PRIMARY | |||
|
DTXSID60956150
Created by
admin on Mon Mar 31 19:00:19 GMT 2025 , Edited by admin on Mon Mar 31 19:00:19 GMT 2025
|
PRIMARY | |||
|
1HLS600135
Created by
admin on Mon Mar 31 19:00:19 GMT 2025 , Edited by admin on Mon Mar 31 19:00:19 GMT 2025
|
PRIMARY | |||
|
C057446
Created by
admin on Mon Mar 31 19:00:19 GMT 2025 , Edited by admin on Mon Mar 31 19:00:19 GMT 2025
|
PRIMARY |